BARIUM SULFATE vs IOHEXOL

Compare BARIUM SULFATE (E-Z-Paque) and IOHEXOL (Omnipaque) — clinical data, side effects, and patient experiences.

BARIUM SULFATE

E-Z-Paque · Diagnostic Agent

How it works

Diagnostic Agent agent

Approved for

1 INDICATIONS AND USAGE Liquid E-Z-PAQUE is indicated for use in single contrast radiographic examinations of the esophagus

stomach

and small bowel to visualize the gastrointestinal (GI) tract in adult and pediatric patients ( 1 )

OralTablet

IOHEXOL

Omnipaque · Diagnostic Agent

How it works

12.1 Mechanism of Action The iodine atoms in iohexol provide attenuation of X-rays in direct proportion to the concentration of iohexol. Since concentration changes over time, iohe...

Approved for

1 INDICATIONS AND USAGE OMNIPAQUE is a radiographic contrast agent indicated for intrathecal

intra-arterial

intravenous

oral

IntravenousTablet

Quick Comparison

BARIUM SULFATEIOHEXOL

Drug Class

Diagnostic Agent

Route

Oral

Intravenous

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

BARIUM SULFATE

Fatigue

1-10%

Nausea

1-10%

Diarrhea

1-10%

Headache

1-10%

Dizziness

1-10%

Drug Not Working

1-10%

Joint Pain

1-10%

Shortness of Breath

1-10%

IOHEXOL

Itching

>10%

Shortness of Breath

>10%

Nausea

1-10%

Vomiting

1-10%

Rash

1-10%

Cough

0.1-1%

Low Blood Pressure

0.1-1%

Fever

0.1-1%

FDA Warnings

BARIUM SULFATE

5 WARNINGS AND PRECAUTIONS Hypersensitivity reactions: Emergency equipment and trained personnel should be immediately available ( 5
3 ) Aspiration pneumonitis: Patients with history of food aspiration or with swallowing disorders are at increased risk ( 5
1 Hypersensitivity Reactions Barium sulfate preparations contain a number of excipients, including natural and artificial flavors and may induce serious hypersensitivity reactions
A history of bronchial asthma, atopy or a previous reaction to a contrast agent may increase the risk for hypersensitivity reactions

IOHEXOL

5 WARNINGS AND PRECAUTIONS Hypersensitivity Reactions: Life-threatening or fatal reactions can occur
Minimize dose and maintain adequate hydration to minimize risk
5 ) Thyroid Dysfunction in Pediatric Patients 0 to 3 Years of Age: Individualize thyroid function monitoring based on risk factors such as prematurity
1 Risks Associated with Intrathecal Administration of OMNIPAQUE Injection 140 mg Iodine/mL and 350 mg Iodine/mL Use only the iodine concentrations and presentations recommended for intrathecal procedures [see Dosage and Administration (2

Clinical Trial Data

No head-to-head clinical studies found for BARIUM SULFATE vs IOHEXOL.

BARIUM SULFATE vs IOHEXOL: What You Should Know

Key Differences

Both BARIUM SULFATE and IOHEXOL belong to the Diagnostic Agent class. While they share a similar mechanism of action, differences in pharmacokinetics, dosing, and side effect profiles may make one more suitable than the other for individual patients. BARIUM SULFATE is administered via Oral, whereas IOHEXOL uses Intravenous. Route of administration can affect onset of action and patient adherence.

Safety Considerations

BARIUM SULFATE carries 4 FDA warnings. IOHEXOL carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

GADOBUTROL vs IOHEXOL→AIR 90% CARBON DIOXIDE 10% vs IOHEXOL→IOHEXOL vs IOPAMIDOL→CARBON DIOXIDE vs IOHEXOL→IODIXANOL vs IOHEXOL→GADODIAMIDE vs IOHEXOL→

Loading comparison data...

BARIUM SULFATE vs IOHEXOL

Compare BARIUM SULFATE (E-Z-Paque) and IOHEXOL (Omnipaque) — clinical data, side effects, and patient experiences.

BARIUM SULFATE

E-Z-Paque · Diagnostic Agent

How it works

Diagnostic Agent agent

Approved for

1 INDICATIONS AND USAGE Liquid E-Z-PAQUE is indicated for use in single contrast radiographic examinations of the esophagus

stomach

and small bowel to visualize the gastrointestinal (GI) tract in adult and pediatric patients ( 1 )

OralTablet

IOHEXOL

Omnipaque · Diagnostic Agent

How it works

12.1 Mechanism of Action The iodine atoms in iohexol provide attenuation of X-rays in direct proportion to the concentration of iohexol. Since concentration changes over time, iohe...

Approved for

1 INDICATIONS AND USAGE OMNIPAQUE is a radiographic contrast agent indicated for intrathecal

intra-arterial

intravenous

oral

IntravenousTablet

Quick Comparison

BARIUM SULFATEIOHEXOL

Drug Class

Diagnostic Agent

Route

Oral

Intravenous

Half-Life

—

FDA Approved

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

BARIUM SULFATE

Fatigue

1-10%

Nausea

1-10%

Diarrhea

1-10%

Headache

1-10%

Dizziness

1-10%

Drug Not Working

1-10%

Joint Pain

1-10%

Shortness of Breath

1-10%

IOHEXOL

Itching

>10%

Shortness of Breath

>10%

Nausea

1-10%

Vomiting

1-10%

Rash

1-10%

Cough

0.1-1%

Low Blood Pressure

0.1-1%

Fever

0.1-1%

FDA Warnings

BARIUM SULFATE

5 WARNINGS AND PRECAUTIONS Hypersensitivity reactions: Emergency equipment and trained personnel should be immediately available ( 5
3 ) Aspiration pneumonitis: Patients with history of food aspiration or with swallowing disorders are at increased risk ( 5
1 Hypersensitivity Reactions Barium sulfate preparations contain a number of excipients, including natural and artificial flavors and may induce serious hypersensitivity reactions
A history of bronchial asthma, atopy or a previous reaction to a contrast agent may increase the risk for hypersensitivity reactions

IOHEXOL

5 WARNINGS AND PRECAUTIONS Hypersensitivity Reactions: Life-threatening or fatal reactions can occur
Minimize dose and maintain adequate hydration to minimize risk
5 ) Thyroid Dysfunction in Pediatric Patients 0 to 3 Years of Age: Individualize thyroid function monitoring based on risk factors such as prematurity
1 Risks Associated with Intrathecal Administration of OMNIPAQUE Injection 140 mg Iodine/mL and 350 mg Iodine/mL Use only the iodine concentrations and presentations recommended for intrathecal procedures [see Dosage and Administration (2

Clinical Trial Data

No head-to-head clinical studies found for BARIUM SULFATE vs IOHEXOL.

BARIUM SULFATE vs IOHEXOL: What You Should Know

Key Differences

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.